31 August 2019
: Case report
A Case of Conjunctival Bee Sting Injury with Review of the Literature on Ocular Bee Stings
Unusual clinical course, Management of emergency care
Axelle Semler-Collery1ABCDEF, George Hayek1E, Sophie Ramadier2E, Jean-Marc Perone1ABCDEF*DOI: 10.12659/AJCR.917592
Am J Case Rep 2019; 20:1284-1289
Abstract
BACKGROUND: Ocular bee stings have been rarely described in the literature, and their management is controversial. A case of conjunctival bee sting with retention of the stinger for 48 hours is presented with a review of the literature on the complications and management of ocular bee sting injury.
CASE REPORT: A 22-year-old beekeeper presented to the Emergency Department with mild symptoms from a conjunctival bee sting that he had received 48 hours previously. The stinger was removed in the Emergency Department, and topical antibiotic and anti-inflammatory treatment with corticosteroid were given. There were no complications in this case. However, review of the literature has shown that although the outcome from ocular bee stings can be mild, as in this case, ocular bee stings can result in severe visual symptoms that require amniotic membrane transplant (AMT). Management commonly includes removal of the stinger and both topical and systemic treatment with corticosteroids. The main complications include cataracts, inflammation of the anterior chamber, optic neuropathies, and changes in ocular pressure.
CONCLUSIONS: Ocular bee stings have been rarely described in the literature, and the management remains controversial. As this case has shown, removal of the stinger and the use of topical treatment with antibiotics and corticosteroids can prevent potentially serious complications that may affect vision. Early and regular follow-up with ocular imaging may be required when symptoms persist.
Keywords: Adaptation, Ocular, Bees, case reports, Conjunctiva, Cornea, Anti-Bacterial Agents, Dexamethasone, Drug Therapy, Combination, Glucocorticoids, Insect Bites and Stings, Ophthalmic Solutions, Tobramycin, young adult
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946452
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946933
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946215
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946869
Most Viewed Current Articles
21 Jun 2024 : Case report
94,087
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,366
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,477
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,076
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030